203 related articles for article (PubMed ID: 31466236)
1. The Human Ovary and Future of Fertility Assessment in the Post-Genome Era.
Ouni E; Vertommen D; Amorim CA
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31466236
[TBL] [Abstract][Full Text] [Related]
2. A woman with polycystic ovary syndrome treated for infertility by in vitro fertilization.
Tang T; Balen AH
Nat Rev Endocrinol; 2009 Aug; 5(8):462-5. PubMed ID: 19629068
[TBL] [Abstract][Full Text] [Related]
3. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
[TBL] [Abstract][Full Text] [Related]
4. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women.
He Y; Lu Y; Zhu Q; Wang Y; Lindheim SR; Qi J; Li X; Ding Y; Shi Y; Wei D; Chen ZJ; Sun Y
Am J Obstet Gynecol; 2019 Aug; 221(2):138.e1-138.e12. PubMed ID: 30910544
[TBL] [Abstract][Full Text] [Related]
5. Metformin treatment before and during in vitro fertilization or intracytoplasmic sperm injection in women with polycystic ovary syndrome: summary of a Cochrane review.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Marjoribanks J; Macedo CR
Fertil Steril; 2015 Sep; 104(3):542-4. PubMed ID: 26070519
[TBL] [Abstract][Full Text] [Related]
6. Oocyte quality in adult polycystic ovary syndrome.
Patel SS; Carr BR
Semin Reprod Med; 2008 Mar; 26(2):196-203. PubMed ID: 18302111
[TBL] [Abstract][Full Text] [Related]
7. Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction.
Kaya C; Pabuccu R; Satıroglu H
Fertil Steril; 2010 Nov; 94(6):2202-7. PubMed ID: 20138267
[TBL] [Abstract][Full Text] [Related]
8. In vitro maturation.
Walls ML; Hart RJ
Best Pract Res Clin Obstet Gynaecol; 2018 Nov; 53():60-72. PubMed ID: 30056110
[TBL] [Abstract][Full Text] [Related]
9. The role of TGF-β in polycystic ovary syndrome.
Raja-Khan N; Urbanek M; Rodgers RJ; Legro RS
Reprod Sci; 2014 Jan; 21(1):20-31. PubMed ID: 23585338
[TBL] [Abstract][Full Text] [Related]
10. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Maheshwari A; Vaidakis D; Bhattacharya S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006606. PubMed ID: 30480769
[TBL] [Abstract][Full Text] [Related]
11. Genetics and Epigenetics of Infertility and Treatments on Outcomes.
Pisarska MD; Chan JL; Lawrenson K; Gonzalez TL; Wang ET
J Clin Endocrinol Metab; 2019 Jun; 104(6):1871-1886. PubMed ID: 30561694
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles.
Marquard KL; Stephens SM; Jungheim ES; Ratts VS; Odem RR; Lanzendorf S; Moley KH
Fertil Steril; 2011 May; 95(6):2146-9, 2149.e1. PubMed ID: 21071018
[TBL] [Abstract][Full Text] [Related]
13. [Quality of oocytes and embryos from women with polycystic ovaries syndrome: State of the art].
Fournier A; Torre A; Delaroche L; Gala A; Mullet T; Ferrières A; Hamamah S
Gynecol Obstet Fertil Senol; 2017; 45(7-8):429-438. PubMed ID: 28757106
[TBL] [Abstract][Full Text] [Related]
14. Treatment of infertility in women with polycystic ovary syndrome.
Bouchard P
Ann Endocrinol (Paris); 2010 May; 71(3):225-7. PubMed ID: 20394912
[TBL] [Abstract][Full Text] [Related]
15. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Vrachnis N; Creatsa M; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2013 Oct; (10):CD006606. PubMed ID: 24101529
[TBL] [Abstract][Full Text] [Related]
16. The fertilization potential of oocytes may be compromised in women with polycystic ovary syndrome.
Jin SG; Son WY; Dahan MH
Minerva Ginecol; 2017 Feb; 69(1):108-109. PubMed ID: 28116888
[No Abstract] [Full Text] [Related]
17. Live birth after in vitro maturation versus standard in vitro fertilisation for women with polycystic ovary syndrome: protocol for a non-inferiority randomised clinical trial.
Zheng X; Guo W; Zeng L; Zheng D; Yang S; Wang L; Wang R; Mol BW; Li R; Qiao J
BMJ Open; 2020 Apr; 10(4):e035334. PubMed ID: 32295778
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization.
Sterling L; Liu J; Okun N; Sakhuja A; Sierra S; Greenblatt E
Fertil Steril; 2016 Mar; 105(3):791-797.e2. PubMed ID: 26654973
[TBL] [Abstract][Full Text] [Related]
19. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
20. In vitro maturation of oocytes: uncommon indications.
Grynberg M; El Hachem H; de Bantel A; Benard J; le Parco S; Fanchin R
Fertil Steril; 2013 Apr; 99(5):1182-8. PubMed ID: 23380185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
